| Product Code: ETC7809883 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Kenya Parkinsons Disease Market Overview |
3.1 Kenya Country Macro Economic Indicators |
3.2 Kenya Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Kenya Parkinsons Disease Market - Industry Life Cycle |
3.4 Kenya Parkinsons Disease Market - Porter's Five Forces |
3.5 Kenya Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Kenya Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Kenya Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Kenya Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Kenya Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Kenya Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about Parkinson's disease in Kenya |
4.2.2 Growing elderly population in Kenya |
4.2.3 Improvements in healthcare infrastructure and access to medical facilities |
4.2.4 Rising investments in research and development for Parkinson's disease treatments |
4.2.5 Government initiatives to improve healthcare services for neurological disorders |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare professionals for Parkinson's disease management |
4.3.2 High cost of Parkinson's disease treatments and medications |
4.3.3 Lack of comprehensive insurance coverage for Parkinson's disease patients |
4.3.4 Stigma and misconceptions associated with neurological disorders in Kenya |
5 Kenya Parkinsons Disease Market Trends |
6 Kenya Parkinsons Disease Market, By Types |
6.1 Kenya Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Kenya Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Kenya Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Kenya Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Kenya Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Kenya Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Kenya Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Kenya Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Kenya Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Kenya Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Kenya Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Kenya Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Kenya Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Kenya Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Kenya Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Kenya Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Kenya Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Kenya Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Kenya Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Kenya Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Kenya Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Kenya Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Kenya Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Kenya Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Kenya Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Kenya Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Kenya Parkinsons Disease Market Export to Major Countries |
7.2 Kenya Parkinsons Disease Market Imports from Major Countries |
8 Kenya Parkinsons Disease Market Key Performance Indicators |
8.1 Average age of diagnosis for Parkinson's disease patients in Kenya |
8.2 Number of healthcare facilities offering specialized care for Parkinson's disease |
8.3 Percentage of Parkinson's disease patients receiving timely and appropriate treatment |
8.4 Rate of adoption of new technologies and treatments for Parkinson's disease |
8.5 Patient satisfaction scores for Parkinson's disease management services in Kenya |
9 Kenya Parkinsons Disease Market - Opportunity Assessment |
9.1 Kenya Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Kenya Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Kenya Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Kenya Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Kenya Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Kenya Parkinsons Disease Market - Competitive Landscape |
10.1 Kenya Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Kenya Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here